BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32003504)

  • 1. Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells.
    Fu S; Liu T; Lv C; Fu C; Zeng R; Kakehi Y; Kulkarni P; Getzenberg RH; Zeng Y
    J Cell Biochem; 2020 Nov; 121(11):4406-4418. PubMed ID: 32003504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.
    Sampson N; Ruiz C; Zenzmaier C; Bubendorf L; Berger P
    Am J Pathol; 2012 Oct; 181(4):1443-54. PubMed ID: 22885105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway.
    Lv C; Fu S; Dong Q; Yu Z; Zhang G; Kong C; Fu C; Zeng Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):24. PubMed ID: 30658679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Stress-response protein prostate-associated gene 4, interacts with c-Jun and potentiates its transactivation.
    Rajagopalan K; Qiu R; Mooney SM; Rao S; Shiraishi T; Sacho E; Huang H; Shapiro E; Weninger KR; Kulkarni P
    Biochim Biophys Acta; 2014 Feb; 1842(2):154-63. PubMed ID: 24263171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
    Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
    Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer.
    Kulkarni P; Dunker AK; Weninger K; Orban J
    Asian J Androl; 2016; 18(5):695-703. PubMed ID: 27270343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
    Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer/testis antigen PAGE4, a regulator of c-Jun transactivation, is phosphorylated by homeodomain-interacting protein kinase 1, a component of the stress-response pathway.
    Mooney SM; Qiu R; Kim JJ; Sacho EJ; Rajagopalan K; Johng D; Shiraishi T; Kulkarni P; Weninger KR
    Biochemistry; 2014 Mar; 53(10):1670-9. PubMed ID: 24559171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
    Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
    Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation-induced Conformational Ensemble Switching in an Intrinsically Disordered Cancer/Testis Antigen.
    He Y; Chen Y; Mooney SM; Rajagopalan K; Bhargava A; Sacho E; Weninger K; Bryan PN; Kulkarni P; Orban J
    J Biol Chem; 2015 Oct; 290(41):25090-102. PubMed ID: 26242913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
    Liang YK; Han ZD; Lu JM; Liu ZZ; Zhuo YJ; Zhu XJ; Chen JX; Ye JH; Liang YX; He HC; Zhong WD
    J Cell Biochem; 2018 Sep; 119(9):7245-7255. PubMed ID: 29797600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
    Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
    FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
    Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth.
    Delsite R; Djakiew D
    Prostate; 1999 Sep; 41(1):39-48. PubMed ID: 10440874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.
    Windus LC; Glover TT; Avery VM
    Mol Cancer; 2013 Sep; 12(1):112. PubMed ID: 24073816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.
    Yuan D; Wang W; Su J; Zhang Y; Luan B; Rao H; Cheng T; Zhang W; Xiao S; Zhang M; Jiang FN; Sun Z; Jia Z; Zhong WD; Zhu J
    Curr Cancer Drug Targets; 2018; 18(9):894-904. PubMed ID: 29295692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-141 inhibits prostatic cancer cell proliferation and migration, and induces cell apoptosis via targeting of RUNX1.
    Xu S; Ge J; Zhang Z; Zhou W
    Oncol Rep; 2018 Mar; 39(3):1454-1460. PubMed ID: 29328406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.